PW Medtech Group (HKSE:01358) 3-Year Revenue Growth Rate : 36.20% (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is PW Medtech Group 3-Year Revenue Growth Rate?

PW Medtech Group's Revenue per Share for the six months ended in Dec. 2023 was HK$0.25.

During the past 12 months, PW Medtech Group's average Revenue per Share Growth Rate was 23.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 36.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was 15.40% per year. During the past 10 years, the average Revenue per Share Growth Rate was -2.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 12 years, the highest 3-Year average Revenue per Share Growth Rate of PW Medtech Group was 36.20% per year. The lowest was -21.70% per year. And the median was -2.00% per year.

Competitive Comparison of PW Medtech Group's 3-Year Revenue Growth Rate

For the Medical Instruments & Supplies subindustry, PW Medtech Group's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PW Medtech Group's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PW Medtech Group's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where PW Medtech Group's 3-Year Revenue Growth Rate falls into.

PW Medtech Group 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

PW Medtech Group (HKSE:01358) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

PW Medtech Group 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of PW Medtech Group's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

PW Medtech Group (HKSE:01358) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PW Medtech Group Ltd (HKSE:01358) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

PWE:Germany

Address

Building 1, No. 23 Panlong West Road, Pinggu District, Beijing, CHN, 101204

Website

https://www.pwmedtech.com

PW Medtech Group Ltd is a medical device company with a focus on fast-growing and high-margin segments of China's medical device industry. The company is engaged in the research and development, manufacturing, and sale of the advanced infusion set, intravenous cannula products, and insulin needles. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens. The company operates through three business segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business.

Executives

Right Faith Holdings Limited	2101 Beneficial owner
Chan Marc	2201 Interest of corporation controlled by you
Fil Limited	2201 Interest of corporation controlled by you
Pandanus Associates Inc.	2201 Interest of corporation controlled by you
Pandanus Partners L.p.	2201 Interest of corporation controlled by you
Fidelity China Special Situations Plc	2101 Beneficial owner
Cross Mark Limited	2101 Beneficial owner
Liu Yufeng	2201 Interest of corporation controlled by you
Zhang Zaixian	2202 Interest of your spouse

PW Medtech Group (HKSE:01358) Headlines

No Headlines